| Business Summary | | Bradley
Pharmaceuticals,
Inc.
markets
over-the-counter
and
prescription
pharmaceuticals,
as
well
as
health-related
products.
The
Company's
product
line
includes
dermatological
brands
(marketed
by
its
wholly
owned
subsidiary,
Doak
Dermatologics,
Inc.)
and
nutritional,
respiratory
and
internal
medicine
brands
(marketed
by
its
Kenwood
Therapeutics
division).
All
its
product
lines
are
manufactured
and
supplied
by
independent
contractors
and
marketed
primarily
to
wholesalers.
The
wholesalers,
in
turn,
distribute
its
products
to
retail
outlets
and
healthcare
institutions
throughout
the
United
States.
The
Company
also
sells
to
distributors
in
selected
international
markets. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Bradley
Pharmaceuticals
manufactures
and
markets
OTC
and
prescription
pharmaceutical
and
health
related
products,
such
as
dermatological,
nutritional,
respiratory,
personal
hygiene
and
internal
medicine
brands.
For
the
six
months
ended
6/30/01,
net
sales
rose
63%
to
$11.2
million.
Net
income
totaled
$852
thousand
vs.
a
loss
of
$4.5
million.
Results
reflect
higher
sales
of
Kenwood's
products
and
Doak's
products
and
the
absence
of
a
$3.9
million
intangible
impairment
charge. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Daniel Glassman, 58 Chairman,
Pres, CEO, | $199K | R. Brent Lenczycki, 29 CFO,
VP | -- | Robert Dubin, R.Ph., 52 Sr.
VP of Sales and Contract Admin. | 143K | Gene Goldberg, 62 Sr.
VP of Marketing and Bus. Planning | 152K | David Wong Sr. VP, Global Sales and Market Devel. | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|